MedTrace Logo

Heartfulness Meditation and Corporate Burnout

NCT04968795 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2021-10-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of a 4-week heart-based meditation practice wellness workshop on burnout and emotional wellness in corporate employees. Corporate employees can be defined as individuals who work in large institutions with greater than 300 employees.

The specific aim of this study is to assess changes in scores measuring symptoms of emotional exhaustion, depersonalization, and personal accomplishment using the Maslach Burnout Index. We hypothesize that the meditation wellness practice will be associated with reduction in burnout for those who take part in the meditation program in comparison to the participants who did not meditate and participate in the wellness program.

Conditions

  • Burnout
  • Meditation
  • Stress
  • Heartfulness

Interventions

OTHER

Heartfulness Meditation

A four-week Heartfulness Wellness seminar, where people are exposed to Heartfulness Meditation and its meditation tools. Participants experience: Heartfulness Guided Relaxation, Heartfulness Meditation and Heartfulness Unwinding/Rejuvenation Technique.

Sponsors & Collaborators

  • Heartfulness Institute

    collaborator OTHER

  • Resolution Blue Labs Inc

    lead INDUSTRY

Principal Investigators

  • Andy Kumar, MD/PhD Candidate · Resolution Blue Labs Inc

  • Aravindhan Ravindhran, MD · Resolution Blue Labs Inc

  • Arth Patel, MD Candidate · Resolution Blue Labs Inc

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2022-04-30
Completion
2022-07-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04968795 on ClinicalTrials.gov